Skip to main content

Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year

Written by Customer Service on . Posted in Public Companies.

Improved image and data acquisition

Improved image and data acquisition
Improved image and data acquisition

Philips Verida spectral CT system, angle view

Philips Verida spectral CT system, angle view
Philips Verida spectral CT system, angle view

Radiologist using web diagnostic viewer

Radiologist using web diagnostic viewer
Radiologist using web diagnostic viewer

i9000 Prestige feature image

i9000 Prestige feature image
i9000 Prestige feature image

January 21, 2026

  • Highest-ranking medical technology company recognized in the Clarivate Top 100 Global Innovators list for 2026
  • Innovations for healthcare professionals and consumers that support better care delivery and improve people’s health and well-being
  • Industry-leading commitment to R&D, with over EUR 1.7 billion invested annually, equivalent to approximately 9% of sales

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been named a Clarivate Top 100 Global Innovator for 2026 for the 13th consecutive year. Philips is the highest-ranking medical technology company included in the report, underscoring its continued leadership in healthcare innovation.

“Building on more than 130 years of innovation, Philips is driven by a clear purpose to deliver better care for more people,” said Roy Jakobs, CEO of Royal Philips. “Our innovations help healthcare professionals deliver high-quality patient care and empower people to manage their health and well-being at home. Being recognized as a Clarivate Top 100 Global Innovator reflects our commitment to people-centered, scalable innovation that improves outcomes and expands access to care.”

Philips’ recognition reflects its long-term commitment to innovation, supported by more than EUR 1.7 billion in annual R&D investment – approximately 9% of sales and among the highest levels in the industry. Across professional healthcare and consumer health, Philips is applying AI-enabled technologies, advanced imaging, and connected platforms to support more precise diagnosis, simplify workflows, and empower people to proactively manage their health and well-being. Examples of Philips’ latest innovations include:

  • Philips Verida, the world’s first detector-based spectral CT powered by integrating AI across the imaging chain, from acquisition to reconstruction.
  • Helium-free [1] MRI magnet technology, led by Philips since 2018, with more than 2,000 installations worldwide and six million liters of liquid helium saved to date, helping hospitals eliminate helium refills and vent pipes.
  • Philips Flash 5100 Point-of-Care Ultrasound, combining advanced imaging clarity and intuitive workflow to support rapid, confident decision-making in frontline clinical settings.
  • A next-generation web-based diagnostic viewer that transforms how radiologists access and interpret medical images, enabling clinicians to work smarter, faster, and more collaboratively.
  • AI-enabled personal care innovations, including the Philips i9000 Shaver Series and advanced hair-removal solutions, deliver more personalized and intuitive self-care experiences for consumers.

The Clarivate Top 100 Global Innovators report uses a complete comparative analysis of global invention data to assess the strength of every patented idea, using measures tied directly to their innovative power. The full Clarivate Top 100 Global Innovators 2026 report can be found here.

[1] Helium-free operations. 7 liters of helium is permanently enclosed in the cryogenic circuit.

For further information, please contact:

Michael Fuchs
Philips Global External Relations
Tel.: +31 614869261
E-mail: Michael.Fuchs@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. 

Attachments

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.